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Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, CaliforniaABSTRACT Arginine-rich motifs (ARMs) capable of binding diverse RNA structures play critical roles in transcription, trans-
lation, RNA trafficking, and RNA packaging. The regulatory HIV-1 protein Rev is essential for viral replication and belongs to
the ARM family of RNA-binding proteins. During the early stages of the HIV-1 life cycle, incompletely spliced and full-length viral
mRNAs are very inefficiently recognized by the splicing machinery of the host cell and are subject to degradation in the cell
nucleus. These transcripts harbor the Rev Response Element (RRE), which orchestrates the interaction with the Rev ARM
and the successive Rev-dependent mRNA export pathway. Based on established criteria for predicting intrinsic disorder,
such as hydropathy, combined with significant net charge, the very basic primary sequences of ARMs are expected to adopt
coil-like structures. Thus, we initiated this study to investigate the conformational changes of the Rev ARM associated with
RNA binding. We used multidimensional NMR and circular dichroism spectroscopy to monitor the observed structural transi-
tions, and described the conformational landscapes using statistical ensemble and molecular-dynamics simulations. The com-
bined spectroscopic and simulated results imply that the Rev ARM is intrinsically disordered not only as an isolated peptide but
also when it is embedded into an oligomerization-deficient Rev mutant. RRE recognition triggers a crucial coil-to-helix transition
employing an induced-fit mechanism.INTRODUCTIONRNA-binding proteins are fundamentally important for
diverse cellular and viral regulatory processes. One wide-
spread RNA-binding domain is the arginine-rich motif
(ARM), which is present in various proteins, such as ribo-
somal proteins, transcriptional antitermination N proteins
of bacteriophages l and P22, and the HIV-1 regulatory
proteins Tat and Rev (1–5). A preponderance of arginine
residues seems to be the only common feature among these
apparently simple and relatively short sequences (10–20
amino acid residues in length). While maintaining the abil-
ity to interact with their cognate targets with high affinity
and specificity (6,7), they have been shown to be surpris-
ingly dynamic and can adopt different conformations,
such as a-helical, b-hairpin, or extended conformations,
after binding their specific RNA targets.
Rev is an ARM-containing RNA-binding protein and a
critical regulator of the HIV-1 replication cycle (8–10). Rev
interacts specifically with a highly structured intronic
element hosted within the Env gene known as the Rev
Responsive Element (RRE), which is part of all intron-con-
taining viral messenger RNAs (mRNAs). Upon recruitment
of proteins that belong to the cellular nuclear-export machin-
ery, Crm1 and the GTPase Ran, Rev induces export of
unspliced and singly splicedmRNA to the cytoplasm for sub-
sequent translation of virion assembly proteins (11–13). To
coordinate these events, Rev must engage in transient pro-
tein-RNA interactions aswell as protein-protein interactions,Submitted March 20, 2013, and accepted for publication July 2, 2013.
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interactions with cellular proteins of the nuclear import and
export machineries. These adaptive recognition processes
require an adequate degree of conformational flexibility.
The Rev ARM comprises 17 amino acid residues,
including a total of 10 arginines (Rev34-50), and in complex
with its cognate RNA, RRE StemIIB, it adopts an a-helical
conformation that fits deeply into the RRE StemIIB widened
major groove (14). Four arginine residues (R35, R38, R39,
and R44), a threonine (T34), and an asparagine (N40)
convey specific, high-affinity binding to RRE StemIIB
(4,14–16). However, Rev ARM has also been shown to
adopt an extended conformation upon binding to anti-Rev
RNA aptamers (15,17). Moreover, interactions with selected
DNA motifs do not require the T34 or N40 side chains (18),
and various arginine residues play key roles in complexes
with distinctly folded RNA targets, including the primary
and secondary binding sites of the RRE (8). Overall, the
variation observed in Rev ARM complex structures suggests
that the conformation of Rev ARM is induced by and depen-
dent upon its specific nucleic acid binding target. Such an
induced-fit or adaptive-binding model has been successfully
applied to describe several protein-protein and protein-
nucleic acid (DNA-RNA) interactions (19–21).
In contrast, early investigations employing circular
dichroism (CD) and NMR suggested that the Rev ARM
is predominantly helical in solution (4,22), supporting a
conformational selection (selected-fit or population-shift)
model (23–27). In this scheme, RRE binding would induce
a shift in the conformational ensemble, resulting in prefer-
ential selection and stabilization of a preformed, helical,http://dx.doi.org/10.1016/j.bpj.2013.07.022
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However, both of these studies optimized conditions to
increase helicity, either by modifying the peptide’s termini
or by working at low pH.
A recently reported x-ray structure of Rev complexed
with an engineered monoclonal Fab (23) and another of
an oligomerization-deficient mutant that forms a homo-
dimer (28,29) both show that Rev’s 65 N-terminal residues
adopt an antiparallel helix-turn-helix architecture, and that
the ARM is helical in these oligomeric complexes. Pivotal
studies employing single-molecule fluorescence have un-
raveled the oligomerization pathway of Rev onto its cognate
RNA target sequence. The initial RRE binding and succes-
sive oligomerization occur in a stepwise manner whereby a
nucleating Rev monomer binds to the high-affinity binding
site StemIIB followed by highly cooperative binding of
additional Rev monomers to form oligomeric assemblies
stabilized by protein-protein and protein-RNA interactions
(30). Dimeric Rev/Rev complexes do not constitute the
basic building block for oligomeric Rev/RRE complex as-
sembly. Because Rev populates a monomeric state only at
submicromolar concentrations (31), RRE-binding-compe-
tent Rev monomers continue to evade structural character-
ization by x-ray crystallography or spectroscopic methods.
In this study, we employed heteronuclear, multidimen-
sional NMR and CD spectroscopy as well as molecular-
dynamics (MD) calculations to investigate whether the
wild-type Rev ARM peptide adopts a helical, RRE-binding
competent conformation in aqueous solution under phy-
siological conditions. Furthermore, we examined the
conformation of the ARM region in the context of an oligo-
merization-deficient Rev variant, the double-mutant
V16D/I55N, which carries mutations in the known oligo-
merization interfaces and permits investigation of a mostly
monomeric state of Rev protein at concentrations suitable
for NMR studies (30). For all of the peptide studies, we
employed a previously described Rev ARM construct that
features the wild-type sequence with four amino acids
(G-4AMA) appended to the N-terminus of Rev34-50 followed
by Aþ1AAAR at the C-terminus (8). To obtain data for a
well-defined helical conformation of the Rev ARM, we
used two preparations: 1), a complex of the Rev ARM pep-
tide with RRE StemIIB in physiological buffer; and 2), the
Rev ARM peptide in 50% 2,2,2-trifluoroethanol (TFE)/50%
physiological buffer. The TFE preparation provided a heli-
cal reference sample without introducing additional signals.MATERIALS AND METHODS
Expression and purification of Rev ARM peptide
and full-length Rev constructs
We cloned and overexpressed the HIV-1 Rev ARM peptide as a cleavable
GB1 fusion in Escherichia coli. The HIV-1 ARM peptide sequence
GAMATRQARRNRRRRWRERQRAAAAR (native amino acids are
underlined (8)) was expressed in E. coli strain BL21/DE3 from a p(H)GB1-derived vector as an N-terminal fusion with a His6 tag, a GB1 domain,
and a TEV-protease cleavage site (32). Plasmids coding for (His6)-tagged
Rev in T7 expression vector (pSG003) were previously described (33).
Cultures of E. coli BL21-CodonPlus (DE3)-RIPL cells expressing (His6)-
tagged Rev wild-type and V16D/I55N mutant were grown from a single
colony in 500 mL 15N- or 15N- and 13C-enriched M9 minimal media at
37C overnight. Cells were grown to OD600 of 0.8 at 37C in LB or M9
media with 100 mg/mL ampicillin. Isopropyl-b-D-thiogalactopyranoside
(IPTG) was added to 1 mM to induce expression for 4 h at 37C, and har-
vested cells were resuspended in denaturing lysis buffer (50 mM Na2HPO4/
NaH2PO4 pH 7.4, 500 mM KCl, 10 mM imidazole, 1 mM dithiothreitol
[DTT] and 8 M urea). A urea denaturation and on-column refolding
protocol was used to remove nonspecific nucleic acid contamination as
previously described (34), and the resulting sample was free of RNA
contamination as determined by the 260/280 nm absorbance ratio (values
of ~0.6) (34). Eluted fractions were analyzed by SDS-PAGE and pooled,
and in the case of the Rev ARM peptide fusion protein, TEV protease
was added and incubated at room temperature overnight. The resulting
peptide was purified by RP-HPLC using a Jupiter Proteo column (Phenom-
enex, Torrance, CA) and a linear gradient of acetonitrile in the presence of
0.1% trifluoroacetic acid (TFA). Collected fractions were pooled and
lyophilized.
For uniform 15N labeling, the constructs were expressed in M9 minimal
medium supplemented with 15NH4Cl[
15N, 99%] (Cambridge Isotope Lab-
oratories, Andover, MA) as the sole nitrogen source. For uniform 15N,13C
labeling, the peptide was expressed in M9 minimal medium supplemented
with 15NH4Cl[
15N, 99%] and 13C-glucose[13C, 99%] (Cambridge Isotope
Laboratories).RNA transcription and purification
RRE StemIIB-containing plasmids were purified with the E.Z.N.A.Plasmid
Giga Kit (Omega Bio-Tek, Norcross, GA), linearized with the appropriate
30 restriction endonuclease, phenol/chloroform extracted, and ethanol
precipitated. DNA template-directed in vitro transcriptions using T7 RNA
polymerase were performed in transcription buffer (40 mM Tris, pH 8.0,
1 mM spermidine, 10 mM DTT, 0.01% Triton X-100) containing
0.05 mg/mL plasmid template, 30 mM MgCl2, 1 mM T7 RNA polymerase,
and 6.5 mM each of ATP, CTP, GTP, and UTP). Transcription reactions
were incubated at 37C for 4 hr.
Transcripts were purified as previously described (35). Briefly, full-
length transcripts were separated from protein, unincorporated nucleotides,
and abortive transcripts by anion exchange chromatography using a
HiTrapQ HP column (GE Healthcare). The RNAwas exchanged into buffer
containing 50 mMNa2HPO4/NaH2PO4 pH 7.4, 150 mMKCl, 1 mM EDTA,
1 mM DTT, 0.02% NaN3). Complex spectra were acquired after addition of
concentrated RRE StemIIB solution to Rev ARM peptide samples (final
molar ratio: 1.1 (RNA) to 1.0 (peptide)).CD spectroscopy
CDmeasurements of purified Rev ARM peptide, wild-type Rev, and V16D/
I55N Rev mutant protein were recorded on an AVIV 400 spectropolarime-
ter (AVIV Biomedical, Lakewood, NJ) at 25C between 198 and 260 nm,
with a 0.1 cm path-length cell, a wavelength increment of 1 nm, an aver-
aging time of 5 s, and an equilibration time of 5 min. The baseline was cor-
rected by subtracting the spectra of the respective buffers collected under
identical conditions. Spectra from three scans were averaged. CD spectra
of 50 mMRev ARM peptide samples in buffer (20 mMNa2HPO4/NaH2PO4
pH 7.4, 150 mM KCl) were acquired in the presence of 0–50% (v/v) TFE,
after preincubation at 25C for 1 h. CD spectra of 10 mMwild-type Rev and
V16D/I55N Rev mutant protein samples were collected in the same buffer
in the absence of TFE. The helical content was estimated using the ratio of
the mean residue ellipticities (q) at 222 and 208 nm.Biophysical Journal 105(4) 1004–1017
1006 Casu et al.NMR spectroscopy: sample preparation
The lyophilized peptide samples were dissolved in a buffer containing
50 mM Na2HPO4/NaH2PO4, pH 7.4, 150 mM KCl, 1 mM EDTA, 1 mM
DTT, 0.02% NaN3 in 500 mL of 90% H2O/10% D2O or 50% TFE/40%
buffer/10% D2O to a final peptide concentration of 1 mM. Aliquots of
wild-type Rev and V16D/I55N Rev mutant protein were buffer exchanged
against Rev NMR buffer (50 mM Na2HPO4/NaH2PO4, pH 7.4, 500 mM
KCl, 1 mM EDTA, 1 mM DTT, 0.02% NaN3) in 500 mL of 90% H2O/
10% D2O to a final protein concentration of ~100–200 mM.NMR data collection and processing
NMR experiments were recorded on Bruker Avance III 600 MHz and
Avance II 700 and 800 MHz spectrometers (Bruker AG, Karlsruhe, Ger-
many). The Avance 700 and 800 are equipped with a 5 mm 1H[13C/15N]
triple-resonance probe featuring cryogenically cooled preamplifiers and
radiofrequency coils on 1H and 13C channels and the z-axis gradient, and
the 600 MHz instrument features a conventional 5 mm 1H[13C/15N] triple-
resonance probe. All NMR experiments were carried out at either 283 or
298 K. 1H chemical shifts were externally referenced to 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS), with heteronuclear13C and 15N chemical
shifts referenced indirectly according to the 1X/1H ratio via DSS.
The NMR data were processed using nmrPipe (36) and analyzed with
CcpNmr analysis software (37).Residual dipolar coupling measurements
For residual dipolar coupling (RDC) measurements, 6% stretched neutral
polyacrylamide gels were cast using the apparatus described by Chou
et al. (38) and prepared from a stock solution of 36% w/v acrylamide
and 0.94% w/v N,N-methylenebisacrylamide (molar ratio of acrylamide/
bisacrylamide of 83:1), 0.08% ammonium persulfate, and 0.7%
tetramethylethylenediamine.
Alkyl-PEG bicelles for RDC measurements were prepared from a 15%
bicelle stock solution (150 mL C12E5, 550 mL NMR buffer, and 300 mL
D2O) according to the protocol described by Gebel and Shortle (39). A
solution of n-hexanol was titrated into the C12E5 solution in microliter
additions up to a molar ratio C12E5/n-hexanol of 0.96. Bicelles were added
to the peptide sample in NMR buffer to make a 6% bicelle sample contain-
ing 1 mM Rev ARM peptide.NMR assignments and structure calculation
Unique backbone and side-chain assignments were made by combining
three-dimensional (3D) HNCO, HNCA, HN(CO)CA, CBCA(CO)NH,
HNCACB, HBHA(CO)NH, and H(CCCO)NH (40); 15N-separated 3D
nuclear Overhauser effect spectroscopy-heteronuclear single quantum
coherence (NOESY-HSQC) (41); HSQC-NOESY-HSQC (42); and 3D
HNHA (43,44) experiments. Analysis of a simultaneous 13C/15N-separated
3D NOESY-HSQC (45) spectrum together with secondary chemical-shift-
derived torsion restraints (46) yielded extensive restraints for structure
elucidation. Isotropic and anisotropic one-bond 1J(HN,N) and 1D(HN,N)
coupling constants were obtained from gradient-enhanced IPAP-HSQC
experiments employing band-selective 1Haliphatic decoupling pulses (47).
Vicinal 3J(HN,Ha) coupling constants were determined using quantitative
HNHA experiments. To compensate for finite 1Ha spin flips, apparent
3J(HN,Ha) couplings were multiplied by a uniform factor of 1.05 (44).
Steady-state, heteronuclear [1HN] 15N NOEs were measured according to
standard procedures (48). Heteronuclear NOE values are reported as the
ratio of peak intensities in paired interleaved spectra collected with and
without the initial proton saturation period (3 s) during the 5 s recycle delay.
Distance restraints were obtained from NOEs in simultaneous, 3D 13C-
and 15N-resolved NOESY experiments, and subsequent assignments ofBiophysical Journal 105(4) 1004–1017interresidue NOE peaks were carried out using the CANDID (49) algorithm
implemented in CYANA 2.1 (L.A. Systems, Tokyo, Japan) (50). For the
structure calculation of the Rev ARM peptide in 50% TFE, we evaluated
a total of 236 intramolecular NOE distance constraints, including 53
medium-range NOEs (see Fig. S2 in the SupportingMaterial). Additionally,
we derived 48 torsion angle constraints from the chemical-shift data using
TALOSþ predictions, and used them in the calculations (46).Generation of conformational ensemble
We generated explicit ensemble descriptions of the Rev ARM peptide using
the flexible-meccano (FM) algorithm (51). The algorithm accounts for the
heteropolymeric nature of the primary sequence and uses amino-acid spe-
cific f,j-torsion angle sampling along with side-chain volumes to compute
the conformational ensemble. The ensemble comprised 100,000 con-
formers, and simulated 1D(HN,N) and 3J(HN,Ha) coupling constants were
averaged over all ensemble members. The Karplus coefficients (3J (Q) ¼
A cos2QþBcosQþC) employed for back calculations were A ¼ 7.9,
B ¼ 1.05, and C ¼ 0.65 Hz (52).MD simulations
MD simulations were generated using the Amber 11 suite of programs (53)
and the ff99SB force field (54) with ILDN side-chain torsion modifications
(55). All simulations used the particle mesh Ewald procedure (56) under
periodic boundary conditions.A time step of 5 fswas used for all simulations,
and the SHAKE algorithm (57) was used to constrain the length of bonds to
hydrogen atoms. Langevin dynamics (58) with a collision frequency of
1 ps1 was used to maintain temperature. All-atom representations of the
molecules were solvated in truncated octahedral boxes of TIP3P water
(59), and charge was neutralized by the addition of 10 chloride ions.
Initial coordinates for the Rev ARM peptide in the unfolding simulation
were taken from Protein Data Bank (PDB) entry 1ETF (14). The N-terminal
Asp residue was replaced with the sequence Gly-Ala-Met-Ala using UCSF
Chimera (60). These four N-terminal residues were added in a parallel
b-strand conformation. Coordinates for the missing hydrogen atoms were
calculated using UCSF Chimera.
To generate multiple unstructured initial coordinates for the folding
simulations, we built an extended peptide in the antiparallel b-strand
conformation using UCSF Chimera and subjected it to 50 steps of steep-
est-descent energy minimization, followed by 50 steps of conjugate-
gradient minimization. The equilibrated extended peptide was heated to
1500 K and held at this temperature for a 500 ps in vacuo trajectory.
The trajectory was clustered, and representative structures from each of
the 10 clusters were solvated using different-sized truncated octahedral
boxes to obtain a similar number of water molecules for each folding
simulation (Table S1).
The solvated systems were energy minimized in two stages. First, the
solvent was minimized with 500 steps of steepest-descent energy minimi-
zation followed by 500 steps of conjugate-gradient minimization with
positional restraints holding the peptide fixed. The second stage minimized
the entire system with 1000 steps of steepest descent followed by 1500
steps of conjugate-gradient minimization. Next, the systems were equili-
brated, again in two stages. Initially, the peptide was held fixed while
the solvent was equilibrated over 20 ps at 1 atm and 283 K. In the second
stage, we equilibrated the entire system over 100 ps by removing the
restraints on the peptide. Production runs of 50 ns were performed in the
NPT ensemble, and coordinates were saved every 5 fs. Trajectories of
each system were extended to 50 ns with a different random number
seed on each restart (61).
Trajectories were analyzed using the Amber ptraj module. Root mean-
square deviations (RMSDs) were calculated using the backbone C, Ca,
and N atoms of all residues unless specified otherwise. Secondary structure
was determined using the DSSP (Define Secondary Structure of Proteins)
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angle Q was defined by the HN, N, Ca, and Ha atoms, to be consistent
with the NMR measurements, and converted to coupling constants using
values of 7.90, 1.05, and 0.65 in the Karplus relationship.RESULTS
CD spectroscopy
CD spectroscopy has been used extensively to study Rev,
and was the first method we applied. CD spectra of the
Rev ARM peptide in physiological buffer exhibited a
minimum around 200 nm, typical of an unfolded state
(Fig. 1 A). Upon titration with TFE, minima appeared atFIGURE 1 TFE-dependent CD of the Rev ARM peptide and CD of Rev
protein variants. (A) Mean residue molar ellipticity q as a function of wave-
length (198–260 nm) for Rev ARM in increasing concentrations of TFE
cosolvent. The double minima at 208 and 222 nm indicate an a-helical sec-
ondary structure in TFE, and the TFE-free spectrum exhibiting a minimum
at ~200 nm is indicative of a more random coil conformation. (B) [q222]/
[q208] ratio as a function of TFE concentration. (C) Mean residue molar
ellipticity q as a function of wavelength (198–260 nm) for wild-type Rev
and V16D/I55N mutant protein in buffer, pH 7.4.208 and 222 nm and the ellipticity progressively increased,
suggesting an increase in helical content. The ratio [q222]/
[q208], a measure of helical content, increased from 0.42
in the absence of TFE to a maximum of 0.82 in the pres-
ence of 50% (v/v) TFE (Fig. 1 B). Accordingly, we chose
to use 50% TFE as a sample condition to provide a refer-
ence helical conformation of the Rev ARM peptide. A
comparison of the CD spectra collected for wild-type
Rev and V16D/I55N Rev mutant protein confirmed signifi-
cant a-helical content for oligomeric wild-type Rev. In
contrast, the oligomerization-deficient Rev double-mutant
V16D/I55N adopted a mostly random coil conformation
(Fig. 1 C).Peptide 1HN,15N-HSQC spectra
To obtain residue-specific information regarding the
Rev ARM peptide, we recorded 1HN,15N-HSQC spectra
(Fig. 2). In aqueous solution, the peptide shows little
dispersion of the resonances (Fig. 2 B), indicative of an
unfolded peptide and in accordance with the CD data. In
contrast, the 1HN,15N-HSQC spectra of the same construct
in 50% TFE (Fig. 2 C) and in complex with RRE StemIIB
(Fig. 2 D) show much greater dispersion. Overall, the
TFE- and RRE StemIIB-induced, weighted amide chemical
shift changes (Dd(1HN,15N)) are similar in magnitude,
averaging 0.31 and 0.34 ppm, respectively. Interestingly,
the majority of the Dd(1HN,15N) values induced by 50%
TFE and RRE-StemIIB binding resemble each other
in direction and magnitude, suggesting that the confor-
mations in the presence of 50% TFE and RRE-StemIIB
are similar. The RRE-StemIIB-induced Dd(1HN,15N) values
of R35 and R44 differ considerably from those induced
by 50% TFE; however, this difference is likely due
to the base-specific contacts these residues make with
opposite sides of the RRE-StemIIB major groove (see
Fig. S1) (14).Wild-type and mutant Rev 1HN,15N-correlation
spectra
NMR investigations of the 116-residue wild-type Rev in
solution are notorious for limited protein solubility and
uncontrolled oligomerization. Therefore, sequential assign-
ments outside the ARM remain unavailable. Fewer than
20% of all backbone amides, all indicative of a disordered
protein region, are observable in 1HN,15N-transverse relax-
ation optimized spectroscopy (1HN,15N-TROSY) spectra
(62) recorded at 283 K (Fig. 3 A). However, because the
V16D/I55N mutations are known to block oligomerization
of Rev on the RRE (30), the introduction of these two
mutations into the protein oligomerization domains
allows for detection of many additional, albeit poorly
dispersed, resonances located in the N-terminal domain of
Rev (Fig. 3 C). Employing conventional through-bondBiophysical Journal 105(4) 1004–1017
FIGURE 2 Resonance dispersion of Rev ARM
in 1H,15N-HSQC spectra. (A) Primary sequence
of the Rev ARM peptide construct investigated.
Nonnative N-terminal residues include G-4 through
A-1, and the C-terminal extension consists of Aþ1
through Rþ5. (B)
1H,15N-HSQC of Rev ARM pep-
tide in NMR buffer (50 mM Na2HPO4/NaH2PO4
pH 7.4, 150 mM KCl, 1 mM EDTA, 1 mM DTT,
0.02% NaN3). (C)
1H,15N-HSQC of the Rev
ARM peptide in 50% TFE/40% NMR buffer/
10% D2O. (D)
1H,15N-HSQC of the Rev ARM
peptide complexed with RRE StemIIB in NMR
buffer. Insets show the side-chain W45 indole
and the T34 backbone amide correlations.
All 1H,15N-HSQC experiments were acquired at
800 MHz and 283 K.
1008 Casu et al.assignment strategies, we were able to sequentially
assign >70% of the backbone amide resonances in the
V16D/I55N Rev mutant construct. Backbone amide assign-
ments obtained for the V16D/I55N Rev mutant could be
transferred to the wild-type spectrum, where they mapped
exclusively to the extreme C-terminus (Fig. 3, A and C).
Although sizable portions of the oligomerization interfaces
centered around helices 1 and 2 are broadened beyond
detectable limits, even in the V16D/I55N Rev mutant
(Fig. 3 D), unambiguous assignments include the N-termi-
nal part of the ARM, spanning residues T34 through N40
(Fig. 3 B). The observed similarities between the backboneBiophysical Journal 105(4) 1004–1017amide chemical shifts in the V16D/I55N Rev mutant
construct and those in the Rev ARM peptide strongly sug-
gest that the adopted confirmation is context independent
and disordered (Fig. 3 B).Secondary chemical shifts
To obtain additional insights into the conformational prefer-
ences of the Rev ARM peptide and the V16D/I55N Rev
mutant, we analyzed the 13Ca and 13Cb secondary chemical
shifts. The difference between 13Ca and 13Cb secondary
chemical shifts for the Rev ARM peptide in aqueous
FIGURE 3 NMR analysis of wild-type Rev and V16D/I55N mutant protein and secondary chemical shifts of Rev V16D/I55N. (A) An 800 MHz
1H,15N-TROSY spectrum of wild-type Rev in NMR buffer containing 500 mM KCl, pH 7.4, recorded at 283 K. Assignments for observable residues are
provided. (B) Inset showing an overlay of 1H,15N-HSQC spectrum of full-length V16D/I55N Rev (single black contour) and Rev ARM peptide (gray
contours) in NMR buffer recorded at 283 K. Arrows and labels indicate the position of assigned residues in the ARM region. (C) An 800 MHz 1H,15N-HSQC
spectrum of full-length V16D/I55N Rev in NMR buffer containing 500 mM KCl, pH 7.4, recorded at 283 K. (D) Combined secondary chemical shifts,
Dd(13Ca,b), of full-length V16D/I55N Rev in NMR buffer, pH 7.4, are plotted against the residue number. The helix-turn-helix motif and functionally impor-
tant ARM/NLS and NES are shown along with the full-length Rev primary sequence. Arrows indicate the position of the two mutations in the Rev oligo-
merization domains (V16D and I55N). Boxed C-terminal residues are assigned in panel A.
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consistent with a random coil-like conformation (Fig. 4
A). In contrast, in the presence of 50% TFE (Fig. 4 B) or
RRE StemIIB (Fig. 4 C), the Rev ARM peptide exhibits dif-
ferences in 13Ca and 13Cb secondary chemical shifts aver-
aging 2.8 and 3.7 ppm, respectively, consistent with an
a-helical conformation. Most of the residues between T34
and R50 have combined 13Ca and 13Cb secondary chemical
shifts between 3 and 4 ppm, characteristic of a fully formed
a-helix (63). Secondary chemical shifts of the oligomeriza-
tion-deficient V16D/I55N Rev mutant confirm that the
C-terminus of Rev is disordered. Furthermore, the observed
deviations from random coil for 13Ca and 13Cb chemical
shifts of residues located in the ARM region (T34 and
Q36–N40) within the V16D/I55N Rev mutant (Fig. 3 D)
are virtually identical to the corresponding secondary chem-
ical shifts in the ARM peptide context. In similarity to theARM peptide scenario, this indicates that residues T34-
N40 do not adopt a stably folded a-helical conformation
in the context of the mostly monomeric V16D/I55N protein
variant.3J(HN,Ha) coupling constants
Fig. 5 A summarizes the 3J(HN,Ha) coupling constants for
Rev ARM peptide in aqueous solution at pH 7.4, in 50%
(v/v) TFE, and in the RRE-bound state. One can interpret
the vicinal coupling data by considering the mean
3J(HN,Ha) values predicted for a-helical and b-strand con-
formations (64). In helical regions, the 3J(HN,Ha) coupling
constants average 5.2 Hz, in b-sheet like conformations
they average 8.5 Hz, and in random coil-like regions, inter-
mediate values ranging from 7.1 to 7.7 Hz are found. For
the Rev ARM peptide in aqueous solution at pH 7.4, weBiophysical Journal 105(4) 1004–1017
FIGURE 4 Secondary structure of Rev ARM as indicated by 13C chem-
ical shift. Combined secondary chemical shifts, Dd(13Ca,b), are plotted as
the difference of experimental 13Ca and 13Cb chemical-shift deviation from
random coil chemical shifts. Dd(13Ca,b) is plotted against residue number
for (A) Rev ARM in NMR buffer, pH 7.4; (B) Rev ARM in 50% TFE; and
(C) Rev ARM in complex with StemIIB (14,65). Carbon chemical shifts for
Rev ARM peptide in complex with RRE StemIIB were taken from Battiste
(65). Native Rev ARM34-50 residues are shown in bold one-letter amino
acid abbreviations, and nonnative residues are indicated by an asterisk.
Values above the dashed line at 2.8 ppm are indicative of an a-helical
conformation.
FIGURE 5 3J(HN,Ha) coupling constants and [1HN]15N-heteronuclear
NOE analysis. (A) Vicinal 3J(HN,Ha) coupling constants for Rev ARM pep-
tide in NMR buffer (black squares) and 50% TFE (gray triangles) were
determined from quantitative HNHA experiments. 3J(HN,Ha) coupling
values for Rev ARM peptide in complex with RRE StemIIB (black circles)
were taken from Battiste (65). Error bars indicate the estimated error in the
three-bond HNHA coupling. (B) [1HN]15N-hetNOEs of Rev ARM peptide
in NMR buffer, pH 7.4 (black squares), in 50% TFE (gray triangles), and in
complex with RRE StemIIB (black circles). Error bars indicate the SD in
the measured values. Native Rev ARM34-50 residues are shown in bold
one-letter amino acid abbreviations, and nonnative residues are indicated
by an asterisk.
1010 Casu et al.observed intermediate 3J(HN,Ha) couplings, with an
average of 6.0 Hz for residues T34–R50. In comparison,
the J couplings of the Rev ARM peptide in 50% TFE are
smaller, with an average value of 4.7 Hz for residues
T34–R50, indicative of the presence of a-helix. Similar
values were reported by Battiste (65) for the a-helical
conformation of the Rev ARM peptide in complex with
RRE StemIIB (with an average value of 4.4 Hz for residues
T34–R50).Backbone dynamics
Analysis of [1HN],15N heteronuclear NOEs (hetNOEs)
conveniently identifies fast-timescale protein backbone
dynamics on a subnanosecond timescale (66). Fig. 5 B
shows that the [1HN],15N hetNOE values for Rev ARM in
aqueous solution at pH 7.4 average 0.47 for residues T34–
R50, consistent with a disordered peptide. In contrast, the
hetNOEs of the Rev ARM peptide in complex with RRE
StemIIB average 0.83 for residues T34–R50, and in 50%
TFE average 0.77 for residues T34–R50. These higher
hetNOE values indicate higher backbone rigidity and are
typical of a well-ordered secondary structure.Biophysical Journal 105(4) 1004–1017Structure calculations
1H, 15N, and 13C chemical-shift assignments of Rev ARM in
the absence and presence of 50% TFE were nearly com-
plete, and assignments have been deposited in the Bio-
MagResBank (accession numbers 18851 and 18852,
respectively).
NOE-derived distance restraints and chemical-shift-
derived backbone torsion restraints were used to calculate
structural ensembles of the Rev ARM peptide in aqueous
solution at pH 7.4 and in 50% TFE. In the case of the phys-
iological sample, the simulated annealing procedure
converged poorly and no single conformation could be
defined that satisfied our experimental chemical shift and
NOE data. In contrast, the data derived from the 50% TFE
sample produced a well-defined helical ensemble. None of
the final ensemble of 20 energy-minimized NMR structures
shown in Fig. 6 A violated NOE distances by more than
0.5 A˚. No torsion angle restraint was violated by more
than 5. The vast majority of residues (99.8%) were found
in the most favored regions of the Ramachandran plot.
The root mean-square deviation (RMSD) of the structure
ensemble compared with the mean structure was 0.87 5
0.35 A˚ for backbone and 1.695 0.32 A˚ for all heavy atoms.
FIGURE 6 NMR solution structure of Rev ARM in 50% TFE. (A)
Ensemble of 20 CYANA conformers representing the solution structure
of the Rev ARM peptide in the presence of 50% (v/v) TFE calculated using
NOE-derived distance-restraints and TALOSþ chemical-shift-derived tor-
sion-angle constraints. (B) Ribbon representation of the mean structure of
Rev ARM in 50% TFE calculated from the ensemble using MolMol (89).
Rev’s Arginine-Rich Motif Is Intrinsically Disordered 1011A summary of the distance restraints and structural statistics
is given in Table S1 and Fig. S2. The Rev ARM peptide in
50% TFE features an a-helical conformation (Fig. 6 B) that
closely resembles the StemIIB-bound state (14) and theFIGURE 7 1D(HN,N) RDC analysis. (A) Experimental 1D(HN,N) values obtai
col) (C12E5) and n-hexanol versus PALES-predicted 1D(HN,N) RDCs calculat
PDB entry 1ETF (14). (B) Correlation between PALES-predicted 1D(HN,N) RD
1D(HN,N) values obtained in C12E5/n-hexanol. The dashed line is the linear r
C12E5/n-hexanol, stretched PAGE gels, and RDCs predicted from 100,000 FM
RDCs and the experimental 1D(HN,N) values obtained in anisotropic C12E5/n-conformation adopted in 20% TFE of a succinylated R42A
point mutant (22), characterized by backbone RMSDs of
0.9 A˚ and 0.7 A˚, respectively (Fig. S3, A and B). The atomic
coordinates and experimental NMR restraints (PDB identi-
fier 2M1A) for the Rev ARM structure in 50% TFE have
been deposited in the PDB (http://www.rcsb.org/).Residual dipolar couplings
To investigate whether residual conformational preferences
exist in aqueous solution at pH 7.4, we oriented the Rev
ARM peptide in stretched acrylamide gels (67) and polye-
thyleneglycol (PEG)/hexanol (68) mixtures to measure
1D(HN,N) RDCs. Although the absolute level of alignment
differed between the two anisotropic environments, very
similar general distributions of 1D(HN,N) emerged (Fig. 7,
A and C). All but two residues at the very C-terminus of
Rev ARM were found to have negative RDCs, with the
largest values in the central residues. RDC values generally
followed a bell-shaped distribution over the sequence, with
small couplings being measured at the N- and C-terminal
extremities. Such distributions have been observed andned in liquid crystalline media composed of n-dodecyl-penta(ethylene gly-
ed assuming steric alignment of Rev ARM peptide coordinates taken from
Cs for the a-helical Rev ARM peptide conformation and the experimental
egression (slope of 2.581). (C) Experimental 1D(HN,N) values obtained in
-generated conformers. (D) Correlation between FM-predicted 1D(HN,N)
hexanol mixture. The dashed line is the linear regression (slope of 1.266).
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1012 Casu et al.rationalized as random coil RDCs and are a direct conse-
quence of the conformational properties embedded into
the primary sequence (69–71).
To rule out the presence of residual a-helical conforma-
tional preferences, we used the PALES software (72) to
predict RDC data based on a steric mode of molecular align-
ment and the a-helical coordinates of the Rev ARM peptide
observed in the complex with RRE StemIIB (PDB identifier
1ETF). A comparison of experimental 1D(HN,N) values
obtained in PEG/hexanol mixtures with those predicted
for the a-helical conformation of the Rev ARM peptide
showed no obvious correlation (Fig. 7 A), as characterized
by a Pearson’s correlation coefficient of 0.493 (Fig. 7 B).
Thus within detectable limits, the experimental 1D(HN,N)
values are inconsistent with the presence of an a-helical
conformation.
Explicitly built conformational ensembles based on
knowledge-based torsion-angle statistics have proved to be
useful for characterizing intrinsically disordered proteins
(IDPs) (73). RDC predictions based on the statistical FM
(51) approach accurately reproduced the experimental
1D(HN,N) values obtained in stretched acrylamide gels and
PEG/hexanol mixtures (Fig. 7 C). The correlation between
experimental PEG/hexanol and FM-predicted 1D(HN,N)
values has a Pearson’s coefficient of 0.842, suggesting that
in aqueous solution at pH 7.4, the Rev ARMpeptide is intrin-
sically disordered (Fig. 7 D). It should be noted that we
corrected variations in the absolute levels of alignment by
applying optimal scaling factors. Collectively, ourRDCanal-
ysis demonstrates that the Rev ARM peptide in aqueous
solution at pH 7.4 populates an ensemble of rapidly intercon-
verting conformations that are mostly unstructured.MD simulations
To further probe the lack of experimental evidence for a he-
lical conformation of the Rev ARM peptide in aqueous so-
lution at pH 7.4, we generated 11 different 50 ns all-atom
explicit-solvent MD simulations. First, an unfolding simula-
tion was started from the a-helical coordinates of the Rev
ARM peptide observed in the NMR solution structure
with RRE StemIIB (PDB identifier 1ETF). The raw
RMSD from the starting coordinates plotted over the course
of the simulation is large and continues to increase, but
calculating the RMSD after superimposing the peptide on
just the native residues (T34–R50) shows that the RMSD
increases in two steps in the first 3 ns of the simulation
and then remains fairly constant around 2 A˚ (Fig. 8 A).
This indicates that after equilibrating over the first 3 ns,
the majority of the motion in the unfolding simulation
occurs in the termini. An examination of the secondary
structure over the course of the unfolding simulation shows
that a structural transition occurs around 3 ns and that the
native residues in the core of the peptide remain predomi-
nantly a-helical throughout the simulation. Visual inspec-Biophysical Journal 105(4) 1004–1017tion of the trajectory confirms the helical conformation of
the Rev ARM peptide. The unfolding simulation suggests
that once the core of the peptide is formed, its helical char-
acter is quite stable over a 50 ns time span (Fig. 8 B).
Since the folded Rev ARM peptide was quite stable in our
unfolding simulation, we decided to test whether the peptide
would fold into a stable a-helix from random coil coordi-
nates. To minimize the influence of the starting conforma-
tion, we generated 10 50-ns-long trajectories, each starting
from different random coil coordinates. To produce starting
coordinates, an extended structure of the Rev ARM peptide
was built, subjected to an in vacuo high-temperature simula-
tion, and then clustered (Fig. S4). To maximize sampling of
conformational space, the temperature and length of the in
vacuo simulation were increased until visualization of the
trajectory revealed that the peptide had contracted and
expanded multiple times, and clustering had produced clus-
ters that were visited multiple times over the course of the
trajectory with no single cluster dominating. Clustering of
the trajectory into 10 clusters provided representative struc-
tures that were used as the starting coordinates for folding
simulations (Fig. S5). Inspection of the secondary structure
over the course of the folding trajectories shows that these
simulations failed to produce any significant a-helical
content (Fig. 9).
To determine whether the simulations were consistent
with the experimental NMR data, we measured the dihedral
angle f for all residues over the course of all 10 folding sim-
ulations and converted the values to mean coupling con-
stants using a Karplus relation (52). The 3J(HN,Ha) values
derived from the simulations averaged ~6.5 Hz, which is
typical of a disordered peptide and consistent with the
experimental values obtained in aqueous solution at pH
7.4 (Fig. S6). To examine the sampling of conformational
space, we combined all 10 folding simulations and grouped
the combined data into 10 clusters (Fig. S7). If conforma-
tional sampling was limited, then each cluster would corre-
spond to one trajectory. If conformational sampling was
extensive, then each cluster would be sampled from each
trajectory. We found that seven of 10 clusters grouped
snapshots from multiple trajectories, and that during all
but one simulation the peptide transitioned to conformations
sampled by other folding trajectories. The folding simula-
tions appear to have sampled the available conformational
space extensively, are consistent with the 3J(HN,Ha)
coupling constants obtained from the aqueous NMR exper-
iments in which the peptide was disordered, and fail to show
any consistent secondary structure formation, suggesting
that on the 50 ns timescale, the Rev ARM peptide does
not transition to an a-helical conformation.DISCUSSION
To date, NMR solution structures of the Rev ARM peptide in
complexwith its high-affinity recognition site, RRE StemIIB
FIGURE 8 Unfolding simulation. (A) RMSD
from starting coordinates over the course of the
unfolding simulation. The upper gray line was
calculated after superimposing the peptide on the
backbone atoms of all residues, and the lower
black line was calculated after superimposing it
on the native residues (T34–R50). (B) Secondary
structure of the Rev ARM peptide over the course
of the unfolding simulation. Secondary structure
was determined with the DSSP algorithm imple-
mented in the Amber ptraj module. Secondary
structure is colored as follows: coil (gray), b-strand
(blue), turn (green), a-helix (red), and 310 helix
(yellow).
Rev’s Arginine-Rich Motif Is Intrinsically Disordered 1013(14), bound to an RNA aptamer (15), and of the N-terminally
succinylated R42A point mutant of Rev ARM at pH 4.7 in the
presence of 20% TFE (22) have been determined. Crystal
structures for the N-terminal helix-turn-helix motif of a
Rev double mutant (28) and one of a complex with mono-
clonal Fab fragments (29) have been solved. Collectively,
these structures demonstrate the helical of Rev ARM upon
RRE binding and homodimerization, and under conditions
with TFE as a cosolvent. In contrast, when it is bound to a
35-mer RNA aptamer, Rev ARM adopts an extended confor-
mation (17). To characterize the conformational state of free
Rev ARM, we first confirmed the previously observed stabi-
lization of a-helical structure by TFE, thereby establishing a
reference helical preparation for comparison studies. Using
heteronuclear 3D NMR spectroscopy, we confirmed that in
50% TFE, the structure of our Rev ARM peptide was very
similar to the succinylated R42Avariant structure determined
in 20%TFE, and to the conformation foundwhen the peptide
is bound to RRE StemIIB.Whenwe compared the NMRdataobtained in 50%TFEwith those obtained in aqueous solution
at pH 7.4, we found no evidence supportive of an a-helical
character of wild-type Rev ARM in aqueous solution at pH
7.4. The strong tendency to self-associate has thus far
thwarted attempts to obtain structural information about
the full-length, wild-type Rev protein on the atomic level.
Mutation ofVal-16 and Ile-55 toAsp-16 andAsn-55 partially
alleviated uncontrolled oligomerization and permitted unam-
biguous assignments for >70% of the backbone residues.
Consistent with previous studies demonstrating the disor-
dered nature of the C-terminus of the Rev L60R variant in
complex with a 42 nt StemIIB hairpin (8,74), our secondary
chemical shifts reveal intrinsic disorder for the C-terminus of
thewild-type and the entire oligomerization-deficient V16D/
I55N Rev variant, including the assignable portion of the
ARM in the absence of the RRE.
To probe for low populations of a-helical ARM peptide
conformations, we measured RDCs in two different align-
ment media. In a recent study, experimental RDCs wereBiophysical Journal 105(4) 1004–1017
FIGURE 9 Folding simulations. Secondary structure of the Rev ARM peptide over the course of the 10 folding simulations. Secondary structure was deter-
mined with the DSSP algorithm implemented in the Amber ptraj module. Secondary structure is colored as follows: coil (gray), b-strand (blue), turn (green),
a-helix (red), and 310 helix (yellow).
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Rev’s Arginine-Rich Motif Is Intrinsically Disordered 1015reproduced with the use of statistical models derived from
backbone conformations sampled in coil-like structures of
the PDB (73). We found that the FM statistical coil model,
which describes an ensemble of unstructured, interconvert-
ing structures, accurately reproduced our experimental
RDC data, whereas an a-helical conformation did not.
Additionally, we generated >500 ns of MD simulations.
Typically, coil-to-helix transitions are thought to be highly
cooperative (75), with helix nucleation times estimated to
be 20–70 ns (76), yet in 10 different 50 ns folding simula-
tions of the Rev ARM peptide, not one coil-to-helix transi-
tion was observed.
The results from our comprehensive CD, NMR, and MD
studies of the Rev ARM peptide under physiological condi-
tions demonstrate that its conformation is most accurately
represented by the FM statistical coil model, which is
most likely a consequence of the abundance of positively
charged arginine residues. Previous CD studies suggested
that the unmodified Rev ARM (T34–R50) adopts a random
coil-like structure, and that the apparent helical content of
ARM peptides depends strongly on terminal modifications
because it was highest for a construct featuring a succiny-
lated N-terminus, a C-terminal extension of four alanines
and one arginine residue, and an amidated C terminus (4).
Similarly, qualitative homonuclear NMR studies suggesting
a helical conformation for the Rev ARM peptide free in so-
lution were performed with an N-succinylated-carboxamide
R42A point mutant and were carried out at pH 4.7 and 4
C,
conditions that were selected because they increased the
structured nature of the peptide (22).
In line with previous investigations that revealed concen-
tration-dependent secondary structure formation for wild-
type Rev and assigned a molten-globular state to the Rev
monomer (77), our CD and NMR investigation of the olig-
omerization-deficient V16D/I55N Rev construct provides
evidence that the ARM region constitutes an intrinsically
disordered element in the absence of binding partners that
can induce its a-helical conformation. The V16D/I55N
Rev variant is predominantly monomeric, even at concentra-
tions required for detailed NMR investigations, which facil-
itated the confirmation of the unstructured nature of Rev
monomers with site-specific resolution.
Because nucleation of Rev assembly at the high-affinity
StemIIB site involves a Rev monomer (10,30,78), we sug-
gest that this initial interaction of the Rev ARM with RRE
StemIIB proceeds via an induced-fit mechanism rather than
by conformational selection. Upon encountering the un-
structured ARM, StemIIB provides specific interactions
that neutralize the positive charge of the numerous argi-
nines and enable formation of the a-helical conformation.
A combination of mutagenesis and CD studies previously
established a correlation between specific StemIIB binding
affinity and a-helical content (4). The R42A variant showed
increased helical content compared with the wild-type
peptide, which in turn lowered the specific Kd as deter-mined by gel-shift experiments from 40 to 35 nM. Combi-
natorial screening of arginine-rich peptide libraries
identified that a glutamine (corresponding to Asn-40 of
the Rev ARM) within a stretch of polyarginine specifically
recognizes StemIIB (79). Further optimization flanked the
glutamine at positions 6, 2, and þ2 with nonarginine
residues featuring aspartic acid, glutamic acid, and alanine
at high frequencies. Since positions 6, 2, and þ2 are
located opposite of the glutamine within a putative
a-helical conformation, it is unlikely that those nonargi-
nine residues are specifically contacting the RRE major
groove. Instead, charge neutralization and stabilization of
the a-helix in general appear to be responsible for the up
to 50-fold higher affinity for StemIIB of these polyargi-
nine-derived peptides compared with the wild-type Rev
ARM (80).CONCLUSIONS
The combination of low hydrophobicity and large net
charge under physiological conditions (pIT34-R50 ¼ 12.6)
predicts intrinsic disorder for the Rev ARM peptide
(81,82). Indeed, our results confirm that the 17-amino-
acid, arginine-rich RNA-binding motif of Rev located
within helix2 of the N-terminal helix-loop-helix motif con-
stitutes an intrinsically disordered sequence element within
the isolated peptide and also in the context of the full-length,
monomeric Rev protein. Our CD, NMR, and MD investiga-
tion of the Rev ARM peptide in aqueous solution at physi-
ological pH reveals a statistical ensemble of interconverting
structures lacking detectable a-helical subpopulations, sug-
gesting that RRE StemIIB recognition by the Rev ARM
occurs via an induced-fit (21) or coupled binding-folding
mechanism (83,84). Our findings outline a principle that
might constitute a general strategy for the ubiquitous class
of arginine-rich RNA-binding proteins to recognize their
diverse and often induced RNA-bound structures (85) while
performing dual functional roles as nuclear localization
signals (86–88).SUPPORTING MATERIAL
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